Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIOCHEMFUSION HOLDING ApS
APS
Active
CVR 35398953
Brødlandsvej 99
Activities of holding companies · NACE 6421
Est. 2013
— employees
www.biochemfusion.com
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 29K
-6% vs 2024
EBITDA margin
71.5%
-15% vs 2024
Equity ratio
95.8%
Financial strength
Net profit 2025
DKK 16K
-83% vs 2024
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
DKK 29K
-6%
EBITDA
DKK 21K
-15%
Net profit
DKK 16K
-83%
Total assets
DKK 237K
-14%
Equity
DKK 227K
-13%
Employees
—
—
Company information
Legal name
BIOCHEMFUSION HOLDING ApS
CVR number
35398953
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
9. juli 2013
Share capital
DKK 80.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren eller af to direktører i forening
Company purpose
Selskabets formål er at eje kapitalandele i andre selskaber og dermed beslægtet virksomhed, herunder at modtage royalties fra andre selskaber
Contact
Address
Brødlandsvej 99
Phone
+4530480050
Email
jan@biochemfusion.com
Website
www.biochemfusion.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Activities of holding companies
Companies in Halsnæs
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
45
21
25
31
29
Staff expenses
-0
-0
-0
-0
-0
EBITDA
39
14
16
24
21
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
39
14
16
24
21
Net financials
148
148
0
75
0
Profit before tax
186
162
16
99
21
Tax
8
3
3
5
5
Net profit
178
159
12
94
16
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
452
455
319
274
237
Equity
446
455
317
261
227
Long-term debt
0
0
0
0
0
Short-term debt
6
0
2
13
10
Total debt
6
0
2
13
10
Financial ratios
5-year trend
EBITDA margin
71.5%
This company
15.8%
Market median
+353% vs market
2021
2025
Equity ratio
95.8%
This company
38.2%
Market median
+151% vs market
2021
2025
Return on equity
7.1%
This company
18.4%
Market median
-61% vs market
2021
2025
Net profit margin
55.8%
This company
8.1%
Market median
+589% vs market
2021
2025
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
2021
2025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JH
Jan Holst Jensen
Management
Management
2013
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
JAN HOLST HOLDING ApS
Company
100%
100%
2013
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
JAN HOLST HOLDING ApS
BIOCHEMFUSION HOLDING ApS
(this company)
BIOCHEMFUSION ApS
Board network connections
Board members of BIOCHEMFUSION HOLDING ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Jan Holst Jensen
Management
0 companies